Literature DB >> 8301278

Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty.

C M Robinson1, J Christie, N Malcolm-Smith.   

Abstract

A study of 160 elective total hip arthroplasties revealed that those patients receiving nonsteroidal antiinflammatory drugs (NSAIDs) in the preoperative period had a significantly increased perioperative blood loss and transfusion requirement when compared with a control group receiving other forms of analgesia for their osteoarthritis. The results suggest that NSAIDs are implicated in increasing the operative blood loss in these patients. The range of increased blood loss varied from 1.57 to 2.08 times the blood loss in the control group, and this effect was seen when the operation was carried out under spinal as well as when under general anesthesia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8301278     DOI: 10.1016/0883-5403(93)90007-q

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  6 in total

Review 1.  Blood management and patient specific transfusion options in total joint replacement surgery.

Authors:  J J Callaghan; A I Spitzer
Journal:  Iowa Orthop J       Date:  2000

Review 2.  [Perioperative pain therapy for knee endoprosthetics].

Authors:  K J Wagner; E F Kochs; V Krautheim; L Gerdesmeyer
Journal:  Orthopade       Date:  2006-02       Impact factor: 1.087

3.  Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Patricia Lavand'homme; JeanCyr Yombi; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-10-29       Impact factor: 4.342

4.  Use of a haemostatic matrix (Floseal®) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin.

Authors:  Pierre-Emmanuel Schwab; Emmanuel Thienpont
Journal:  Blood Transfus       Date:  2015-05-29       Impact factor: 3.443

5.  Preemptive versus postoperative lumiracoxib for analgesia in ambulatory arthroscopic knee surgery.

Authors:  Joachim Grifka; Rudolf Enz; Joachim Zink; Jean Louis Hugot; Andreas Kreiss; Udayasankar Arulmani; Vincent Yu; Rosemary Rebuli; Gerhard Krammer
Journal:  J Pain Res       Date:  2008-11-01       Impact factor: 3.133

6.  Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial.

Authors:  Qianyu Zhuang; Yanyan Bian; Wei Wang; Jingmei Jiang; Bin Feng; Tiezheng Sun; Jianhao Lin; Miaofeng Zhang; Shigui Yan; Bin Shen; Fuxing Pei; Xisheng Weng
Journal:  BMJ Open       Date:  2016-09-08       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.